Aarti Pharmalabs Limited (NSE:AARTIPHARM)

Market Cap	83.97B
Revenue (ttm)	19.46B
Net Income (ttm)	2.66B
Shares Out	90.64M
EPS (ttm)	29.38
PE Ratio	31.53
Forward PE	n/a
Dividend	5.00 (0.54%)
Ex-Dividend Date	Sep 15, 2025

Volume	227,316
Average Volume	367,293
Open	928.70
Previous Close	926.35
Day's Range	913.85 - 942.50
52-Week Range	557.05 - 971.00
Beta	-0.50
RSI	62.44
Earnings Date	Oct 28, 2025

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 2,162
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AARTIPHARM

Financial Performance

In 2024, Aarti Pharmalabs's revenue was 21.15 billion, an increase of 14.17% compared to the previous year's 18.53 billion. Earnings were 2.72 billion, an increase of 25.59%.